皮林林通过减少炎症和调节肠道微生物群,减轻小鼠DSS诱导的性结肠炎
Bin Lv1, Lu Hou2, Haolong Zhang3
1Health Examination Center, China-Japan Union Hospital of Jilin University, PR China.
概括
皮潘内林通过减少炎症和修复肠道屏障来缓解性结肠炎 (UC). 这种化合物还调节肠道微生物群,为UC患者提供潜在的治疗益处.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 微生物学 微生物学
背景情况:
- 丁,一种烯胺,对性结肠炎 (UC) 有未知的影响.
- 在硫酸 (DSS) 诱导的UC模型中研究皮门对开发新的UC治疗非常重要.
研究的目的:
- 调查pimpinellin在DSS诱导UC的小鼠模型中的治疗效果和潜在机制.
- 为了探索pimpinellin对肠道炎症,屏障功能和肠道微生物群组成的影响.
主要方法:
- 利用硫酸 (DSS) 诱导的小鼠模型来模拟性结肠炎.
- 给出了皮林林,并评估了它对结肠长度,肠道屏障完整性,炎症标志物和肠道微生物群的影响.
- 分析了pimpinellin对MAPK/NF-κB信号通路和肠道屏障蛋白的蛋白质表达的影响.
主要成果:
- 在DSS诱导的UC小鼠中,impinellin治疗显著降低了结肠缩短和肠壁损伤.
- 皮林林的使用降低了促炎性细胞因子的水平,并抑制了MAPK/NF-κB信号通路.
- 皮林林治疗促进了有益的肠道益生菌 (例如S24-7,乳酸菌群) 和减少有害细菌 (例如肠杆菌群),100毫克/公斤显示显著的疗效.
结论:
- 皮林因缓解炎症,保持肠道屏障完整性,并重新平衡肠道微生物群而有效地缓解DSS诱导的UC.
- 这些研究结果表明,皮门林在治疗性结肠炎方面具有重要的药物应用潜力.
- 调节肠道微生物群的pimpinellin呈现了一个有前途的治疗策略UC管理.
相关概念视频
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
356
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
356
Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
349
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
349
Peptic Ulcer Disease I: Introduction
133
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
133
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
316
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
316


